PROTOPORPHYRIA

Clinical trials for PROTOPORPHYRIA explained in plain language.

Never miss a new study

Get alerted when new PROTOPORPHYRIA trials appear

Sign up with your email to follow new studies for PROTOPORPHYRIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Liver-Focused drug study for rare Light-Sensitivity disease halted before start

Disease control Terminated

This study was designed to see if bitopertin is safe and can lower harmful protoporphyrin IX levels in people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) who also have early signs of liver damage. It was withdrawn before enrolling any participants, s…

Matched conditions: PROTOPORPHYRIA

Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control

Last updated May 20, 2026 11:53 UTC

PROTOPORPHYRIA

Get alerted when new PROTOPORPHYRIA trials appear

Liver-Focused drug study for rare Light-Sensitivity disease halted before start